358 related articles for article (PubMed ID: 11207517)
41. Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Tankovic J; Lamarque D; Lascols C; Soussy CJ; Delchier JC
Pathol Biol (Paris); 2001 Sep; 49(7):528-33. PubMed ID: 11642014
[TBL] [Abstract][Full Text] [Related]
42. Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Gschwantler M; Dragosics B; Schütze K; Wurzer H; Hirschl AM; Pasching E; Wimmer M; Klimpfinger M; Oberhuber G; Brandstätter G; Hentschel E; Weiss W
Aliment Pharmacol Ther; 1999 Aug; 13(8):1063-9. PubMed ID: 10468682
[TBL] [Abstract][Full Text] [Related]
43. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
[TBL] [Abstract][Full Text] [Related]
44. Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Marko D; Calvet X; Ducons J; Guardiola J; Tito L; Bory F;
Helicobacter; 2005 Feb; 10(1):22-32. PubMed ID: 15691312
[TBL] [Abstract][Full Text] [Related]
45. A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine.
Liu WZ; Xiao SD; Hu PJ; Lu H; Cui Y; Tytgat GN
Aliment Pharmacol Ther; 2000 Nov; 14(11):1519-22. PubMed ID: 11069324
[TBL] [Abstract][Full Text] [Related]
46. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
[TBL] [Abstract][Full Text] [Related]
47. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Salmanroghani H; Mirvakili M; Baghbanian M; Salmanroghani R; Sanati G; Yazdian P
PLoS One; 2018; 13(6):e0197096. PubMed ID: 29889843
[TBL] [Abstract][Full Text] [Related]
49. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
[TBL] [Abstract][Full Text] [Related]
50. To compare the efficacy of triple therapy with furazolidone, amoxicillin and omeprazole for two weeks and three weeks in the eradication of Helicobacter pylori in Bangladeshi duodenal ulcer patients.
Saha SK; Saha SK; Masud H; Islam N; Raihan AS; Roy PK; Hasan M
Bangladesh Med Res Counc Bull; 2011 Dec; 37(3):83-7. PubMed ID: 22352226
[TBL] [Abstract][Full Text] [Related]
51. Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
Nie Y; Li Y; Wu H; Sha W; Du H; Dai S; Wang H; Li Q
Helicobacter; 1999 Jun; 4(2):128-34. PubMed ID: 10382127
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic options after failed Helicobacter pylori eradication therapy.
van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN
Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413
[TBL] [Abstract][Full Text] [Related]
53. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.
Liang X; Xu X; Zheng Q; Zhang W; Sun Q; Liu W; Xiao S; Lu H
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):802-7.e1. PubMed ID: 23376004
[TBL] [Abstract][Full Text] [Related]
55. Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.
Wong WM; Xiao SD; Hu PJ; Wang WH; Gu Q; Huang JQ; Xia HH; Wu SM; Li CJ; Chen MH; Cui Y; Lai KC; Hu WH; Chan CK; Lam SK; Wong BC
Aliment Pharmacol Ther; 2005 Jan; 21(1):73-81. PubMed ID: 15644048
[TBL] [Abstract][Full Text] [Related]
56. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
[TBL] [Abstract][Full Text] [Related]
57. Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.
Xie Y; Zhu Y; Zhou H; Lu ZF; Yang Z; Shu X; Guo XB; Fan HZ; Tang JH; Zeng XP; Wen JB; Li XQ; He XX; Ma JH; Liu DS; Huang CB; Xu NJ; Wang NR; Lu NH
World J Gastroenterol; 2014 Aug; 20(32):11415-21. PubMed ID: 25170230
[TBL] [Abstract][Full Text] [Related]
58. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Sung JJ; Leung WK; Ling TK; Yung MY; Chan FK; Lee YT; Cheng AF; Chung SC
Aliment Pharmacol Ther; 1998 Aug; 12(8):725-30. PubMed ID: 9726384
[TBL] [Abstract][Full Text] [Related]
59. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
60. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Ahuja V; Dhar A; Bal C; Sharma MP
Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]